THROAT CANCER
Clinical trials for THROAT CANCER explained in plain language.
Never miss a new study
Get alerted when new THROAT CANCER trials appear
Sign up with your email to follow new studies for THROAT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take on HPV cancers
Disease control Recruiting nowThis study tests a new immunotherapy for people with advanced HPV-related cancers (cervical, throat, anal, and others). Participants receive specially engineered immune cells designed to attack HPV-infected tumor cells, along with chemotherapy and a drug to boost cell activity. T…
Matched conditions: THROAT CANCER
Phase: PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated May 16, 2026 22:32 UTC
-
New hope for hard-to-treat HER2 cancers: drug shows promise in real-world study
Disease control Recruiting nowThis study looks at how well the drug T-DXd works in adults with advanced HER2-positive solid tumors that have spread and are not responding to other treatments. About 100 people will be followed to see if their tumors shrink and how long that lasts. The goal is to provide a trea…
Matched conditions: THROAT CANCER
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 16, 2026 22:32 UTC
-
Could less radiation be just as effective for HPV throat cancer?
Disease control Recruiting nowThis study is for people with HPV-positive throat cancer. It tests whether a much lower dose of radiation (30 Gy) combined with standard chemotherapy works as well as the usual high dose (70 Gy) to control the cancer, while causing fewer side effects. About 121 participants will …
Matched conditions: THROAT CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 16, 2026 22:30 UTC